Growth Metrics

Resmed (RMD) Receivables - Net (2016 - 2025)

Resmed's Receivables - Net history spans 16 years, with the latest figure at $985.6 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 14.62% year-over-year to $985.6 million; the TTM value through Dec 2025 reached $985.6 million, up 14.62%, while the annual FY2025 figure was $939.5 million, 12.21% up from the prior year.
  • Receivables - Net reached $985.6 million in Q4 2025 per RMD's latest filing, up from $907.3 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $985.6 million in Q4 2025 to a low of $508.6 million in Q1 2022.
  • Average Receivables - Net over 5 years is $723.0 million, with a median of $698.6 million recorded in 2023.
  • Peak YoY movement for Receivables - Net: decreased 6.24% in 2022, then skyrocketed 34.94% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $526.0 million in 2021, then rose by 27.8% to $672.3 million in 2022, then increased by 8.55% to $729.7 million in 2023, then rose by 17.84% to $859.9 million in 2024, then increased by 14.62% to $985.6 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Receivables - Net are $985.6 million (Q4 2025), $907.3 million (Q3 2025), and $939.5 million (Q2 2025).